KAKossi Dovene Abalo

Kossi Dovene Abalo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kossi Dovene Abalo has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Klervi Leuraud

    PSE-SANTE/SESANE/Laboratory of Epidemiology, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, Île-de-France, France

    3 shared publications
  • Marie-Odile Bernier

    PSE-SANTE/SESANE/Laboratory of Epidemiology, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, Île-de-France, France

    3 shared publications
  • Mark P. Little

    Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA

    3 shared publications
  • Michael Hauptmann

    Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany

    3 shared publications
  • Alexandra Albertsson-Lindblad

    Department of Clinical Sciences Lund, Division of Oncology, Skåne University Hospital, Lund University

    2 shared publications
  • David B. Richardson

    Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, USA

    2 shared publications

Latest Publications

  • Risque de cancer et exposition aux rayonnements ionisants lors des procédures de cardiologie interventionnelle en pédiatrie au sein de la cohorte COCCINELLE

    by Kossi DovénÊ Abalo

    L’objectif de cette thèse était d’approfondir les connaissances sur les risques de cancers dans l’enfance associés avec une exposition pédiatrique aux rayonnements ionisants dans le cadre d’une imagerie diagnostique, notamment pour les patients pédiatriques porteurs d’une malformation cardiaque qui peuvent bénéficier d’une ou de plusieurs procédures de cathétérisme cardiaque dans le cadre de leur prise en charge et qui sont associées à de faibles doses de rayonnements ionisants. Les enfants ont une radiosensibilité plus élevée aux rayonnements ionisants que les adultes cependant, peu de connaissances existent sur les effets à long terme de ces expositions médicales. Une première partie de la thèse a consisté à réaliser une revue de la littérature et une méta-analyse sur les risques de cancer associés aux expositions médicales diagnostiques utilisant les rayonnements ionisants. Une deuxième partie avait pour objectif d’évaluer le risque de cancer après exposition aux rayonnements ionisants lors des procédures de cathétérisme cardiaque pendant l’enfance.L’analyse du risque de cancer a été faite au sein de la cohorte COCCINELLE incluant 17 104 enfants en France métropolitaine ayant reçu une procédure de cathétérisme cardiaque entre 2000 et 2013, avant l’âge de 16 ans. L’incidence tous cancers dans la population étudiée était trois fois plus élevée qu’en population générale, mais n’était plus significativement différente de celle de la population générale après exclusion des enfants présentant un facteur de prédisposition au cancer. Aucune association significative avec la dose d’irradiation reçue n’a été observée pour le risque de survenue de cancer hématopoïétique. L’existence de certains de facteurs de prédisposition aux cancers, plus fréquents chez ces patients que dans la population générale, pourrait expliquer en partie l’excès de cancers observé. Une prolongation du suivi de la cohorte et l’inclusion de l’étude dans le projet européen Harmonic permettra d’augmenter la puissance statistique des analyses afin d’étudier si une partie de l’excès observé pourrait être lié à la dose d’irradiation reçue.

  • Open Access

    Survival in mantle cell lymphoma patients burdened by a second primary malignancy

    by Kossi D. Abalo, Trine Trab, Joachim Baech, Sara Ekberg, Simon Pahnke, Alexandra Albertsson-Lindblad, Karin E. Smedby, Mats Jerkeman, Peter Brown, Thomas Stauffer Larsen, et al.

    Second primary malignancies (SPMs) increasingly affect mantle cell lymphoma (MCL) survivors. In nationwide Danish and Swedish cohorts (2000-2020), we evaluated overall survival among MCL patients with SPMs versus matched non-lymphoma individuals with comparable malignancies and MCL patients without SPMs, respectively. Of 3094 MCL survivors, 19% in Denmark and 15% in Sweden developed an SPM, with a median of three years from MCL diagnosis to first SPM. MCL patients with SPMs had about double the mortality risk compared with non-lymphoma counterparts (pooled HR 2.1, 95% confidence interval (CI) 1.3-3.5), and worse survival than MCL patients without SPMs (pooled HR 1.6, 95% CI 1.4-1.9). In Swedish MCL patients with SPMs, deaths were attributed to subsequent hematologic malignancies (9%), solid cancers (14%), primary MCL (23%), non-cancer causes (11%), with 40% still alive. Development of SPMs in MCL is associated with substantially higher mortality, supporting long-term surveillance and proactive management of late complications.

  • Open Access

    Infections in patients with mantle cell lymphoma

    by Kossi D. Abalo, Sara Ekberg, Therese M. L. Andersson, Simon Pahnke, Alexandra Albertsson‐Lindblad, Karin E. Smedby, Mats Jerkeman, Ingrid Glimelius

    Advancements in treatments have significantly improved the prognosis for mantle cell lymphoma (MCL), and there is a growing population of survivors with an increased susceptibility to infections. We assessed the incidence of infections by clinical characteristics and treatment both before and after MCL diagnosis in Sweden. Patients with a diagnosis of MCL ≥ 18 years between 2007 and 2019 were included, along with up to 10 matched comparators. Infectious disease diagnosis and anti‐infective drug dispensation were identified by the National Patient and the Prescribed Drug Registers, respectively. Patients and comparators were followed from the diagnosis/matching date until death, emigration, or June 30, 2020. Overall, 1559 patients and 15,571 comparators were followed for a median duration of 2.9 and 5 years, respectively. The infection rate among patients was twofold higher, RRadj = 2.14 (2.01–2.27), contrasted to the comparator group. There was a notable rise in infection rates already 4 years before MCL diagnosis, which reached a fourfold increase in the first year after diagnosis and persisted significantly increased for an additional 8 years. Among patients, 69% ( n = 1080) experienced at least one infection during the first year of follow‐up. Influenza, pneumonia, other bacterial infections, urinary tract infections, and acute upper respiratory infections were the most frequent. Notably, MCL remained to be the primary leading cause of death among patients (57%, n = 467/817). Infections as the main cause of death were rare (2.6%, n = 21). Our study highlights the importance of thoroughly assessing infectious morbidity when appraising new treatments. Further investigations are warranted to explore strategies for reducing infectious disease burden.


  • Open Access

    Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses

    by Mark P. Little, Richard Wakeford, Simon D. Bouffler, Kossi Abalo, Michael Hauptmann, Nobuyuki Hamada, Gerald M. Kendall


  • Open Access

    Exposure to low-dose ionising radiation from cardiac catheterisation and risk of cancer: the COCCINELLE study cohort profile

    by Kossi Dovene Abalo, Sophie Malekzadeh-Milani, Sébastien Hascoët, Serge Dreuil, Tiphaine Feuillet, Sarah Cohen, Claire Dauphin, Sylvie Di Filippo, Stéphanie Douchin, François Godart, et al.

    Purpose The COCCINELLE study is a nationwide retrospective French cohort set up to evaluate the risk of cancer in patients who undergone cardiac catheterisation (CC) procedures for diagnosis or treatment of congenital heart disease during childhood. Participants Children who undergone CC procedures from 1 January 2000 to 31 December 2013, before the age of 16 in one of the 15 paediatric cardiology departments which perform paediatric CC in mainland France were included. The follow-up started at the date of the first recorded CC procedure until the exit date, that is, the date of death, the date of first cancer diagnosis, the date of the 18th birthday or the 31 December 2015, whichever occurred first. The cohort was linked to the National Childhood Cancer Registry to identify patients diagnosed with cancer and with the French National Directory for the Identification of Natural Persons to retrieve the patients’ vital status. Findings to date A total of 17 104 children were included in the cohort and followed for 110 335 person-years, with 22 227 CC procedures collected. Among the patients, 81.6% received only one procedure. Fifty-nine cancer cases were observed in the cohort. Standardised incidence ratios (SIRs) were increased for all-cancer (SIR=3.8, 95% CI: 2.9 to 4.9), leukaemia (SIR=3.3, 95% CI: 2.0 to 5.4), lymphoma (SIR=14.9, 95% CI: 9.9 to 22.5) and solid cancers excluding central nervous system (CNS) tumours (SIR=3.3, 95% CI: 2.0 to 5.5) compared with the general population. Future plans Dose reconstruction is currently underway to estimate individual cumulative doses absorbed to relevant organs, including red bone marrow and brain for respectively haematologic disorders and CNS tumours risk estimation. A dose–response analysis will be conducted with consideration to confounding factors such as age at exposure, gender, predisposing factors to cancer and other sources of medical diagnostic low-dose ionising radiation.


  • Methodological improvements to meta-analysis of low dose rate studies and derivation of dose and dose-rate effectiveness factors

    by Mark P. Little, David J. Pawel, Kossi Abalo, Michael Hauptmann

    Epidemiological studies of cancer rates associated with external and internal exposure to ionizing radiation have been subject to extensive reviews by various scientific bodies. It has long been assumed that radiation-induced cancer risks at low doses or low-dose rates are lower (per unit dose) than those at higher doses and dose rates. Based on a mixture of experimental and epidemiologic evidence the International Commission on Radiological Protection recommended the use of a dose and dose-rate effectiveness factor for purposes of radiological protection to reduce solid cancer risks obtained from moderate-to-high acute dose studies (e.g. those derived from the Japanese atomic bomb survivors) when applied to low dose or low-dose rate exposures. In the last few years there have been a number of attempts at assessing the effect of extrapolation of dose rate via direct comparison of observed risks in low-dose rate occupational studies and appropriately age/sex-adjusted analyses of the Japanese atomic bomb survivors. The usual approach is to consider the ratio of the excess relative risks in the two studies, a measure of the inverse of the dose rate effectiveness factor. This can be estimated using standard meta-analysis with inverse weighting of ratios of relative risks using variances derived via the delta method. In this paper certain potential statistical problems in the ratio of estimated excess relative risks for low-dose rate studies to the excess relative risk in the Japanese atomic bomb survivors are discussed, specifically the absence of a well-defined mean and the theoretically unbounded variance of this ratio. A slightly different method of meta-analysis for estimating uncertainties of these ratios is proposed, motivated by Fieller’s theorem, which leads to slightly different central estimates and confidence intervals for the dose rate effectiveness factor. However, given the uncertainties in the data, the differences in mean values and uncertainties from the dose rate effectiveness factor estimated using delta-method-based meta-analysis are not substantial, generally less than 70%.


  • Open Access

    Correction to: early life ionizing radiation exposure and cancer risks: systematic review and meta-analysis

    by Kossi D. Abalo, Estelle Rage, Klervi Leuraud, David B. Richardson, Hubert Ducou Le Pointe, Dominique Laurier, Marie-Odile Bernier

    The original version of Table 2 included two incorrect values.


  • Early life ionizing radiation exposure and cancer risks: systematic review and meta-analysis

    by Kossi D. Abalo, Estelle Rage, Klervi Leuraud, David B. Richardson, Hubert Ducou Le Pointe, Dominique Laurier, Marie-Odile Bernier

    Background Ionizing radiation use for medical diagnostic purposes has substantially increased over the last three decades. Moderate to high doses of radiation are well established causes of cancer, especially for exposure at young ages. However, cancer risk from low-dose medical imaging is debated. Objective To review the literature on cancer risks associated with prenatal and postnatal medical diagnostic ionizing radiation exposure among children and to assess this risk through a meta-analysis. Materials and methods A literature search of five electronic databases supplemented by a hand search was performed to retrieve relevant epidemiological studies published from 2000 to 2019, including patients younger than 22 years of age exposed to medical imaging ionizing radiation. Pooled odds ratio (ORpooled) and pooled excess relative risk (ERRpooled) representing the excess of risk per unit of organ dose were estimated with a random effect model. Results Twenty-four studies were included. For prenatal exposure (radiographs or CT), no significant increased risk was reported for all cancers, leukemia and brain tumors. For postnatal exposure, increased risk was observed only for CT, mostly for leukemia (ERRpooled=26.9 Gy−1; 95% confidence interval [CI]: 2.7–57.1) and brain tumors (ERRpooled=9.1 Gy−1; 95% CI: 5.2–13.1). Conclusion CT exposure in childhood appears to be associated with increased risk of cancer while no significant association was observed with diagnostic radiographs.